Rinvoq ER 45 MG tablet UU 28S
Ended Awarded Last action
- Contract number
- SPE2DR26FJE0L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $53,588
Award facts
- Contract value 100% obligated
- $53,587.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $53,587.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count units) on December 16, 2025, with an ultimate completion date of December 17, 2025. The award was competitively placed with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this delivery order under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
RINVOQ (upadacitinib) is a Janus kinase inhibitor used in the treatment of rheumatoid arthritis and other inflammatory conditions. The delivery order represents a specific pharmaceutical procurement within AmerisourceBergen's broader relationship with the Defense Logistics Agency, which regularly sources brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies for military and veteran healthcare systems. The three-day completion window reflects the expedited nature of this particular pharmaceutical shipment to support military medical operations and supply chain requirements.
Quick answers
Who was awarded contract SPE2DR26FJE0L?
SPE2DR26FJE0L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FJE0L worth?
The government has obligated $53,588 on SPE2DR26FJE0L.
Is contract SPE2DR26FJE0L an order under another contract?
Yes. SPE2DR26FJE0L is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJE0L competed?
The extent of competition for SPE2DR26FJE0L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award